Cargando…
Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptors
For effective targeted therapy of cancer with chemotherapy-loaded nanoparticles (NPs), antigens that are selective for cancer cells should be targeted to minimise off-tumour toxicity. Human leukocyte antigens (HLAs) are attractive cancer targets as they can present peptides from tumour-selective pro...
Autores principales: | McDaid, William J., Lissin, Nikolai, Pollheimer, Ellen, Greene, Michelle, Leach, Adam, Smyth, Peter, Bossi, Giovanna, Longley, Daniel, Cole, David K., Scott, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447836/ https://www.ncbi.nlm.nih.gov/pubmed/34533174 http://dx.doi.org/10.1039/d1nr04001d |
Ejemplares similares
-
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
por: Chen, Hongbo, et al.
Publicado: (2010) -
Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy
por: Oh, Keun Sang, et al.
Publicado: (2016) -
Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast
Cancer Therapy
por: Zhang, Xueyan, et al.
Publicado: (2019) -
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
por: Jurczyk, Magdalena, et al.
Publicado: (2022) -
Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer
por: Chen, Yang, et al.
Publicado: (2022)